Table 1.

Correlation of ARID1a, BRG1 and BRM expression for the entire patients cohort

	ARID1a expression						BRG1 expression						BRM expression
		Negative		Positive		p-value		Negative		Positive		p-value		Negative		Positive		p-value
Total	560*	58	10.4%	502	89.6%		563*	19	3.4%	544	96.6%		578*	57	9.9%	521	90.1%
Sex
Female	65	7	10.8%	58	89.2%	0.831	67	1	1.5%	66	98.5%	0.715	68	11	16.2%	57	83.8%	0.080
Male	495	51	10.3%	444	89.7%		496	18	3.6%	478	96.4%		510	46	9.0%	464	91.0%
Age group
<65	185	17	9.2%	168	90.8%	0.399	186	4	2.2%	182	97.8%	0.239	191	20	10.5%	171	89.5%	0.199
>65	174	19	10.9%	155	89.1%		170	9	5.3%	161	94.7%		173	20	11.6%	153	88.4%
pT stage
1	81	9	11.1%	72	88.9%	0.657	79	3	3.8%	76	96.2%	0.448	86	8	9.3%	78	90.7%	0.981
2	72	8	11.1%	64	88.9%		73	1	1.4%	72	98.6%		72	6	8.3%	66	91.7%
3	385	41	10.6%	344	89.4%		388	13	3.4%	375	96.6%		398	41	10.3%	357	89.7%
4	19	0	0%	19	100%		20	2	10%	18	90.0%		20	2	10.0%	18	90.0%
Lymph node metastasis
pN0	217	31	14.3%	186	85.7%	0.086	216	8	3.7%	208	96.3%	0.952	227	20	8.8%	207	91.2%	0.651
pN 1	196	13	6.6%	183	93.4%		197	6	3%	191	97.0%		194	23	11.9%	171	88.1%
pN 2	74	7	9.5%	67	90.5%		74	2	2.7%	72	97.3%		79	6	7.6%	73	92.4%
pN 3	71	7	9.9%	64	90.1%		74	3	4.1%	71	95.9%		76	8	10.5%	68	89.5%
Grading
G1	4	1	25%	3	75%	0.186	5	0	0%	5	100%	< 0.001	6	0	0%	6	100%	0.119
G2	218	16	7.3%	202	92.7%		217	3	1.4%	214	98.6%		221	20	9.0%	201	91.0%
G3	167	22	13.2%	145	86,8%		172	10	5.8%	162	94.2%		177	24	13.6%	153	86.4%

*Total numbers of patients do not add due to missing clinical data in some cases